• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Down 0.18%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    80.74 Down 1.40(1.70%) 4:00PM EDT
    |After Hours : 80.00 Down 0.74 (0.92%) 5:58PM EDT
    Prev Close:82.14
    Open:82.16
    Bid:79.66 x 100
    Ask:84.91 x 100
    1y Target Est:114.79
    Beta:1.57024
    Earnings Date:Aug 1 - Aug 5 (Est.)
    Day's Range:79.32 - 82.63
    52wk Range:62.12 - 151.75
    Volume:1,074,125
    Avg Vol (3m):1,781,070
    Market Cap:13.10B
    P/E (ttm):N/A
    EPS (ttm):-1.07
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BMRN

    Comparison

    Symbol% ChgMkt Cap
    BMRNDown 1.70%13.10B
    FOLDDown 4.11%824.47M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.91
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-2.12
    Quarterly EPS Est (Jun-16) :-0.45
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-1.61

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback